RETRACTED: A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction (Retracted article. See vol. 25, pg. 897, 2011)

被引:46
作者
De Hert, Stefan G. [1 ]
Lorsomradee, Suraphong [1 ]
vanden Eede, Herve [1 ]
Cromheecke, Stefanie [1 ]
Van der Linden, Philippe J. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Div Cardiothorac & Vasc Anesthesiol, Dept Anesthesiol, NL-1100 AZ Amsterdam, Netherlands
关键词
cardiac surgery; levosimendan; milrinone; cardiac bypass;
D O I
10.1053/j.jvca.2008.02.019
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: To evaluate the effects of 2 different administration modalities of levosimendan (start before cardiopulmonary bypass [CPB] and at the end of CPB) compared with a standard treatment with milrinone started at the end of CPB in cardiac surgery patients with a preoperative ejection fraction < 30%. Design: A prospective study. Setting: A university hospital. Participants: Sixty patients undergoing elective cardiac surgery with CPB. Interventions: Patients were randomly assigned to 3 different treatment options for weaning from CPB after cardiac surgery. Group A received milrinone, 0.5 mu g/kg/min, after the release of the aortic cross-clamp; group B received levosimendan, 0.1 mu g/kg/min, after the induction of anesthesia; and in group C, levosimendan, 0.1 mu g/kg/min, was started immediately after the release of the aortic cross-clamp. In all patients, additional dobutamine, 5 mu g/kg/min, was initiated after the release of the aortic cross-clamp. Norepinephrine maintained mean arterial pressure constant. Measurements and Main Results: Stroke volume after surgery was initially higher than at baseline in all groups and highest in group B. Stroke volume declined 12 hours after surgery in group A but not in groups B and C (p < 0.05 between groups), despite similar filling pressures. Four patients in group A, none in group 13, and 1 in group C died within 30 days of surgery. Postoperative atrial fibrillation was observed in 10 patients in group A, 7 patients in group C, and only 1 in group B (p < 0.01). No differences were observed in postoperative troponin I release among groups. Conclusion: In the conditions of the present study, starting the levosimendan treatment before CPB was associated with a higher initial postoperative stroke volume and a lower incidence of postoperative atrial fibrillation, but had no effect on the extent of postoperative troponin I release. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:699 / 705
页数:7
相关论文
共 38 条
  • [1] Levosimendan in off-pump coronary artery bypass - A four-times masked controlled study
    Barisin, S
    Husedzinovic, I
    Sonicki, Z
    Bradic, N
    Barisin, A
    Tonkovic, D
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2004, 44 (06) : 703 - 708
  • [2] Levosimendan may improve survival in patients requiring mechanical assist devices for post-cardiotomy heart failure
    Braun, Jan-Peter
    Jasulaitis, Dominik
    Moshirzadeh, Maryam
    Doepfmer, Ulrich R.
    Kastrup, Marc
    von Heymann, Christian
    Dohmen, Pascal M.
    Konertz, Wolfgang
    Spies, Claudia
    [J]. CRITICAL CARE, 2006, 10 (01):
  • [3] Cardioprotective properties of sevoflurane in patients undergoing aortic valve replacement with cardiopulmonary bypass
    Cromheecke, Stefanie
    Pepermans, Veronik
    Hendrickx, Ellen
    Lorsomradee, Sur
    ten Broecke, Pieter W.
    Stockman, Bernard A.
    Rodrigus, Inez E.
    De Hert, Stefan G.
    [J]. ANESTHESIA AND ANALGESIA, 2006, 103 (02) : 289 - 296
  • [4] Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration
    De Hert, SG
    Van der Linden, PJ
    Cromheecke, S
    Meeus, R
    Nelis, A
    Van Reeth, V
    ten Broecke, PW
    De Blier, IG
    Stockman, BA
    Rodrigus, IE
    [J]. ANESTHESIOLOGY, 2004, 101 (02) : 299 - 310
  • [5] Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass
    De Hert, SG
    Van der Linden, PJ
    Cromheecke, S
    Meeus, R
    ten Broecke, PW
    De Blier, IG
    Stockman, BA
    Rodrigus, IE
    [J]. ANESTHESIOLOGY, 2004, 101 (01) : 9 - 20
  • [6] The effects of levosimendan in cardiac surgery patients with poor left ventricular function
    De Hert, Stefan G.
    Lorsomradee, Suraphong
    Cromheecke, Stefanie
    Van der Linden, Philippe J.
    [J]. ANESTHESIA AND ANALGESIA, 2007, 104 (04) : 766 - 773
  • [7] Evidence-based use of levosimendan in different clinical settings
    De Luca, Leonardo
    Colucci, Wilson S.
    Nieminen, Markku S.
    Massie, Barry M.
    Gheorghiade, Mihai
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (16) : 1908 - 1920
  • [8] COMPARISON OF 2 DIFFERENT LOADING DOSES OF MILRINONE FOR WEANING FROM CARDIOPULMONARY BYPASS
    DEHERT, SG
    MOENS, MM
    JORENS, PG
    DELRUE, GL
    DEPAEP, RJ
    VERMEYEN, KM
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1995, 9 (03) : 264 - 271
  • [9] DESPOTIS GJ, 1994, J THORAC CARDIOV SUR, V107, P271
  • [10] Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial
    Follath, F
    Cleland, JGF
    Just, H
    Papp, JGY
    Scholz, H
    Peuhkurinen, K
    Harjola, VP
    Mitrovic, V
    Abdalla, M
    Sandell, EP
    Lehtonen, L
    [J]. LANCET, 2002, 360 (9328) : 196 - 202